Breathing in a new era: a comparative analysis of lung cancer policies in Taiwan, South Korea and Japan
The battle against lung cancer calls for immediate attention to improve policies, programmes, and treatment accessibility. The goal? To curb its incidence, enhance health outcomes, and uplift the quality of life for those grappling with this deadly disease.
In our previous study, “Breathing in a New Era”, we evaluated lung cancer policies across 10 Asia-Pacific countries. Now, we turn our focus to Taiwan, South Korea, and Japan. How have things evolved in these economies? How can we strengthen the policies? How can we guarantee better access to treatment, thereby addressing this escalating crisis in the region?
Which territories are making strides, and where do the voids in our efforts lie?
Please watch our video, “Uncovering policy gaps to manage the growing lung cancer crisis in Taiwan, South Korea, and Japan,” (Youtube ↗) and stay tuned for our upcoming 2024 report, where we delve into a comparative analysis of lung cancer policies across Taiwan, Japan, and South Korea. This exploration will shed light on the progress made and the challenges that remain in our collective fight against lung cancer.